CTI and Spectrum form JV for marketing of Zevalin; ended
- Radiopharmaceuticals, Contrast Agents
- Large Molecule
- Includes Royalty or Profit Split Information
- Joint Venture
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.